{"disease":{"id":"aids-related-kaposi-s-sarcoma","name":"aids related kaposi s sarcoma"},"drugs":{"marketed":[{"drug_id":"chembl-chembl428647","indication_name":"AIDS-related Kaposi's sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PACLITAXEL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Microtubule Inhibitor [EPC]","quality_score":37,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01057121","title":"Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT01016730","title":"Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01752569","title":"A Study of Selumetinib in Patients With Kaposi's Sarcoma","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":19,"lead_sponsor_name":"Sheffield Teaching Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT04893018","title":"NT-I7 for Kaposi Sarcoma in Patients With or Without HIV","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}